NCT06460337 Comparative Effects of Modified Otago and Frenkel's Exercises in Geriatric Population
| NCT ID | NCT06460337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Geriatrics |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-03-20 |
| Primary Completion | 2024-09-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-03-20 with a primary completion date of 2024-09-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized clinical trial is to compare the effects of modified Otago and Frenkel's exercises on balance, motor function, fear of fall and quality of life in the geriatric population. The main questions it aims to answer are: * How modified Otago and Frenkel's exercises affect balance, motor function, fear of fall and quality of life in the geriatric population? * Is there any difference between the effects of these two exercises? Researchers will compare the effects of modified Otago and Frenkel's exercises to see which kind of exercise has superior effects on the mentioned outcomes. Participants will be randomly divided into two groups who will perform their respective exercises for 45 minutes 3 days a week for 8 weeks. Outcomes will be evaluated at the baseline, 4th week and 8th week.
Eligibility Criteria
Inclusion Criteria: * Community-dwelling adults of both genders who have experienced a fall at least once in the previous year * Minimum Berg Balance score of \>40 * Able to independently walk and perform everyday activities without any walking aid Exclusion Criteria: * Unable to walk independently. * Previous surgeries related to knee or hip joint replacement. * Severe comorbidities such as stroke, unstable coronary artery disease, Parkinson's disease, and epilepsy. * Patients with mental illness such as schizophrenia, dementia, and Alzheimer's disease * Uncorrected visual, auditory, or vestibular impairments * Having limb defects or any physical disability that prevents performing the exercises
Contact & Investigator
Wajiha Shahid, PhD
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06460337 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 80 Years, studying Geriatrics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06460337 currently recruiting?
Yes, NCT06460337 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06460337 trial being conducted?
This trial is being conducted at Pindi Bhattian, Pakistan.
Who is sponsoring the NCT06460337 clinical trial?
NCT06460337 is sponsored by Riphah International University. The principal investigator is Wajiha Shahid, PhD at Riphah International University. The trial plans to enroll 44 participants.